Ignite Creation Date:
2024-05-06 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05271630
Status:
RECRUITING
Last Update Posted:
2024-02-14
First Post:
2022-02-28
Brief Title:
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine outcomes for Multiple Myeloma patients on maintenance single agent vs doublet IMiD PI combination chemotherapy post Autologous Stem Cell Transplant ASCT
Detailed Description:
This non-interventional cohort prospective research study will assess outcomes for Multiple Myeloma patients on maintenance single agent vs doublet IMiD PI combination chemotherapy post ASCT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None